Company attributes
Industry
Location
Pitchbook URL
Number of Employees (Ranges)
11 – 500
Email Address
contactus@cepturtx.com
Full Address
1 ILENE COURT, BLDG. 8, UNIT 9 HILLSBOROUGH, NJ 08844
CIK Number
Investors
Founded Date
2021
Total Funding Amount (USD)
149,999,978
Latest Funding Round Date
March 8, 2022
Latest Funding Type
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
74,999,978
Ceptur is developing unique and differentiated genetic medicines for patients with unaddressed diseases. The Company’s wholly owned and proprietary U1 Adaptor technology promotes non-genotoxic and long-lasting silencing of disease-causing genes in difficult to target tissues (i.e., outside of the liver and CNS).
Timeline
No Timeline data yet.
